GOLDMAN SACHS GROUP INC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 43 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$42,000
-82.9%
10,755
-48.7%
0.00%
Q4 2020$246,000
+148.5%
20,984
+10.1%
0.00%
Q3 2020$99,00019,0610.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$29,465,0003.85%
Ikarian Capital, LLC 2,716,840$31,787,0001.40%
Telemetry Investments, L.L.C. 10,223$120,0000.20%
Vigilare Wealth Management 14,000$164,0000.16%
BOOTHBAY FUND MANAGEMENT, LLC 294,031$3,440,0000.13%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$983,0000.13%
NEA Management Company, LLC 346,718$4,057,0000.11%
GSA CAPITAL PARTNERS LLP 46,375$543,0000.09%
683 Capital Management, LLC 75,000$878,0000.04%
MGO ONE SEVEN LLC 16,000$187,0000.04%
View complete list of TRACON PHARMACEUTICALS INC shareholders